BBIO vs FAST · rev $221.9M vs P/E 43, rev $7.55B
BridgeBio Pharma Inc (BBIO) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
BBIO currently screens at market cap $13.24B. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the BBIO and FAST stock pages for the full models.
Not investment advice.